Baxter International (BAX) Segment Reporting, Other Segment Item, Amount — Quarterly & Annual

Screener

Segment Reporting, Other Segment Item, Amount at other companies

PRA GroupPRAA

$35.48M-6.5%

ConocoPhillipsCOP

$7.45B+42.3%

Matthews InternationalMATW

-$18.78M-1,081%

Collegium Pharmaceutical, Inc.COLL

$25.48M+4,316%

Radiant LogisticsRLGT

-$271K-113%

Microbot MedicalMBOT

$557K+7.3%

Other financials

Income statement

Revenue$2.7B+2.9%

Gross profit$891.0M+3.5%

Operating income$66.0M+13.8%

Net income-$15.0M-112%

EPS (diluted)-$0.03-112%

Balance sheet

Cash & equivalents$2.0B-12.1%

Total debt$224.0M-8.9%

Total equity$6.0B-14.7%

Total assets$19.8B-6.8%

Cash flow

Operating cash flow$213.0M+210%

CapEx$128.3M+15.0%

Free cash flow$83.0M-42.1%

Valuation

Market cap$14.13B+22.3%

Enterprise value$12.33B+22.1%

P/S1.3×+0.2×

Profitability

Gross margin30.1%-5.9pp

Operating margin-2.7%—

Net margin-9.7%+62.5pp

FCF margin3%-2.4pp

Returns & leverage

Return on equity-16.7%-76.7pp

Debt / equity0×0.0×

Current ratio1.9×-0.2×